Drug Targets – Products

Download this app note to discover an automated immunoprecipitation method that offers seamless integration to protein analysis, ensures high yield and reproducibility as well as delivers low nonspecific binding with significant reductions in total and hands-on time.

Aptamer Group has announced the extension of their current agreement with AstraZeneca. This agreement will further the existing collaboration to evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates.

Dotmatics Ltd, has announced that it has entered a licensing agreement with Compugen. The multi-year agreement will provide Compugen scientists based at the Company’s R&D facility in Israel with a single information management platform.

One of the common molecular analyses is the determination of a lead molecule’s binding kinetics and affinity to the target. This warrants the need for analytical instruments capable of characterizing such molecules. Download this whitepaper to discover an approach that accurately measures multiple high-affinity interactions over long run times.

BioMed X announces the successful completion of its first joint research project with Boehringer Ingelheim in neuroscience.

Porvair Sciences reports it has agreed with its collaborative partners to make additional investment in the CEAT project.

PhoreMost Limited and Oxford Biomedica plc today announced that they have entered into a discovery collaboration to develop next-generation CAR-T cell therapies.

Download this app note to discover more about binding parameters and high-throughput assays in drug development.

Immunoprecipitation in its basic form is very simple, however protein–protein binding often involves transient and weak interactions. It is therefore paramount to use a method that offers rapid binding kinetics and low nonspecific binding.

Access this whitepaper to discover how the analytical techniques that can facilitate research, development and quality control during drug development.